HB1638

Interim Study (House)

creating a bypass mechanism for health insurer step therapy protocols when medically necessary.

House Commerce and Consumer Affairs 2026 Session

Status

Introduced

House Committee

House Vote

Senate

Senate Vote

Governor

Interim Study (House)

No upcoming hearing scheduled.

Support 43

Oppose 5

Neutral 3

51 total submissions

Refer for Interim Study: MA VV 03/11/2026 HJ 7

House

March 11, 2026

Committee Report: Refer for Interim Study 02/18/2026 (Vote 15-0; CC) HC 10 P. 9

House

March 03, 2026

Executive Session: 02/18/2026 01:00 pm GP 229

House

February 11, 2026

Full Committee Work Session: 02/18/2026 10:00 am GP 229

House

February 11, 2026

Public Hearing: 02/17/2026 11:00 am GP 159

House

February 10, 2026

Introduced 01/07/2026 and referred to Commerce and Consumer Affairs

House

December 10, 2025

Loading bill text...